Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Alkermes plc (ALKS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.60+0.45 (+1.72%)
At close: 04:00PM EDT
26.60 0.00 (0.00%)
After hours: 04:34PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close26.15
Open25.96
Bid26.57 x 800
Ask27.50 x 1800
Day's Range25.96 - 26.81
52 Week Range21.24 - 33.00
Volume1,508,942
Avg. Volume1,536,983
Market Cap4.369B
Beta (5Y Monthly)0.60
PE Ratio (TTM)N/A
EPS (TTM)-0.38
Earnings DateJul 27, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est31.78
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ALKS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Alkermes plc
    Analyst Report: Vertex Pharmaceuticals, Inc.Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 3,500 employees. It has research programs and facilities in the U.S., the U.K., and Canada. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
Advertisement
Advertisement